AbbVie Клинические исследования
-
Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain
-
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who
-
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With
-
BOTOX Effects on Seizure Severity and Susceptibility
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
-
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Diseas
-
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
-
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperpara
-
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
-
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With
-
Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episo
-
Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
-
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care A
-
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure
-
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects,
Исследования по компаниям
PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & JohnsonBristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan